Miyuki Suguro

1.2k citations
34 papers · 878 indexed · h-index 16
Topics
Lymphoma Diagnosis and Treatment (13 papers)Multiple Myeloma Research and Treatments (7 papers)T-cell and Retrovirus Studies (5 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Miyuki Suguro

34 papers receiving 860 citations

Peers

Miyuki Suguro
Comparison fields: 5 of 87
  • Oncology 309
  • Molecular Biology 245
  • Pathology and Forensic Medicine 228
  • Epidemiology 180
  • Infectious Diseases 168
Replace Christophe Legendre with:
Christophe Legendre United States
Keiichi Ohsato Japan
Philippe Moulin Belgium
Paul E. Hurtubise United States
Nathalie Balandraud France
F Isnard France
Damien Roos‐Weil France
Dolores Subirá Spain
Yoshio Ozaki Japan
Patrick Duthilleul France
Miyuki Suguro relative to Christophe Legendre United States Christophe Legendre's profile →
Citations per field
00.5×1.7×
Christophe Legendre · 1×
Citations per year

Countries citing papers authored by Miyuki Suguro

Since Specialization
Citations

This map shows the geographic impact of Miyuki Suguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Suguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Suguro more than expected).

Fields of papers citing papers by Miyuki Suguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Suguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Suguro. The network helps show where Miyuki Suguro may publish in the future.

Co-authorship network of co-authors of Miyuki Suguro

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Suguro. A scholar is included among the top collaborators of Miyuki Suguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Suguro. Miyuki Suguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 18
3 34
4 14
5 49
6 28
7 28
8 40
9 44
10 11
11 16
12 12
13 11
14 83
15 4
16 1
17 12
18 34
19 6
20 15

About Miyuki Suguro

Miyuki Suguro is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 34 papers that have together received 878 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Multiple Myeloma Research and Treatments (7 papers) and T-cell and Retrovirus Studies (5 papers). The work is most often cited by research in Hematology (163 citations), Pathology and Forensic Medicine (228 citations) and Genetics (130 citations). Miyuki Suguro has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Masao Seto, Rie Yamamoto, Atsushi Togawa, Tamae Hamaki, Naoki Takezako, Aki Chizuka, Akiyoshi Miwa, Yoshinobu Kanda, Tomohiro Matsuyama and Shigeo Nakamura. Their work appears in journals such as Blood, Bioinformatics and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026